Filing Analysis
Regulation FD Disclosure
Filed Mar 26, 2026
LOW
Rani Therapeutics Holdings, Inc. announced its financial results for the fourth quarter and fiscal year ended December 31, 2025. The filing includes a press release with a corporate update and was signed by CFO Svai Sanford.
Key Facts
- Financial results reported for the fourth quarter and full year ended December 31, 2025
- Press release issued and furnished on March 26, 2026
- Filing includes Item 2.02 (Results of Operations and Financial Condition)
- Exhibit 99.1 contains the full text of the earnings press release
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.